Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients

Jianping Liu,1 Weihua Zhao,2 Qinghong Gui,1 Ying Zhang,1 Zaiyu Guo,2 Wei Liu3 1Department of Neurology, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 2Department of Neurosurgery, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 3Department o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu J, Zhao W, Gui Q, Zhang Y, Guo Z, Liu W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/569af6e1e66f48bba1c0427cc4f4b6be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:569af6e1e66f48bba1c0427cc4f4b6be
record_format dspace
spelling oai:doaj.org-article:569af6e1e66f48bba1c0427cc4f4b6be2021-12-02T14:17:44ZAddition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients1178-2021https://doaj.org/article/569af6e1e66f48bba1c0427cc4f4b6be2021-01-01T00:00:00Zhttps://www.dovepress.com/addition-of-abeta42-to-total-cerebral-small-vessel-disease-score-impro-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Jianping Liu,1 Weihua Zhao,2 Qinghong Gui,1 Ying Zhang,1 Zaiyu Guo,2 Wei Liu3 1Department of Neurology, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 2Department of Neurosurgery, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 3Department of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of ChinaCorrespondence: Zaiyu GuoDepartment of Neurosurgery, Tianjin TEDA Hospital, No. 65, The Third Avenue, Tianjin Economy Development Area, Tianjin 300457, People’s Republic of ChinaTel +86-15302100230Email guozaiyu_teda@163.comWei LiuDepartment of Neurology, Tianjin Medical University General Hospital, No. 154, An Shan Road, Heping District, Tianjin 300052, People’s Republic of ChinaTel +86-2260362255Email liuweithird@126.comPurpose: To investigate the associations between concentrations of Aβ40 and Aβ42 and vascular cognitive impairment (VCI) in cerebral small vessel disease (CSVD) patients and evaluate the value of combination of levels of Aβ40 or Aβ42 and the total CSVD score in predicting VCI.Patients and Methods: A total of 199 CSVD patients were divided into VCI group and non-VCI group according to the criteria of VCI. Demographic data, MRI markers of CSVD, blood pressure, vascular risk factors, laboratory markers, and serum Aβ40 and Aβ42 concentration were collected. Univariate analysis was performed with the Student’s t-test, Mann–Whitney U-test or Chi-square test. Variables with P< 0.10 in univariate analysis were then included in multivariate analysis that used a backward stepwise logistic regression model. The predictive values were assessed with receiver operating characteristic (ROC) curve.Results: VCI was determined in 112 CSVD patients (56.3%). Hyperlipidemia (OR: 1.618, 95% CI: 1.265– 3.049), the total CSVD score (OR: 1.414, 95% CI: 1.213– 2.278) and serum Aβ42 concentration (OR: 1.401, 95% CI: 1.212– 1.946) were independent risk factors for VCI in CSVD patients with adjustment for age, education years, diabetes and fasting blood-glucose (FBG). The area under curves (AUCs) were 0.640 (SE: 0.040, 95% CI: 0.563– 0.718), 0.733 (SE: 0.035, 95% CI: 0.664– 0.802) and 0.827 (SE: 0.030, 95% CI: 0.768– 0.887), respectively, for the total CSVD score, serum Aβ42 concentration and their combination applied in predicting VCI in CSVD patients. Z test demonstrated that the AUC of combination prediction was significantly higher than individual prediction (0.827 vs 0.640, Z=3.740, P< 0.001; 0.827 vs 0.733, Z=2.039, P=0.021).Conclusion: Combination of Aβ42 and total CSVD score could significantly elevate the predictive value of cognitive impairment in CSVD patients.Keywords: Aβ40, Aβ42, vascular cognitive impairment, cerebral small vessel disease, total cerebral small vessel disease scoreLiu JZhao WGui QZhang YGuo ZLiu WDove Medical Pressarticleaβ40aβ42vascular cognitive impairmentcerebral small vessel diseasetotal cerebral small vessel disease scoreNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 195-201 (2021)
institution DOAJ
collection DOAJ
language EN
topic aβ40
aβ42
vascular cognitive impairment
cerebral small vessel disease
total cerebral small vessel disease score
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle aβ40
aβ42
vascular cognitive impairment
cerebral small vessel disease
total cerebral small vessel disease score
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Liu J
Zhao W
Gui Q
Zhang Y
Guo Z
Liu W
Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
description Jianping Liu,1 Weihua Zhao,2 Qinghong Gui,1 Ying Zhang,1 Zaiyu Guo,2 Wei Liu3 1Department of Neurology, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 2Department of Neurosurgery, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 3Department of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, People’s Republic of ChinaCorrespondence: Zaiyu GuoDepartment of Neurosurgery, Tianjin TEDA Hospital, No. 65, The Third Avenue, Tianjin Economy Development Area, Tianjin 300457, People’s Republic of ChinaTel +86-15302100230Email guozaiyu_teda@163.comWei LiuDepartment of Neurology, Tianjin Medical University General Hospital, No. 154, An Shan Road, Heping District, Tianjin 300052, People’s Republic of ChinaTel +86-2260362255Email liuweithird@126.comPurpose: To investigate the associations between concentrations of Aβ40 and Aβ42 and vascular cognitive impairment (VCI) in cerebral small vessel disease (CSVD) patients and evaluate the value of combination of levels of Aβ40 or Aβ42 and the total CSVD score in predicting VCI.Patients and Methods: A total of 199 CSVD patients were divided into VCI group and non-VCI group according to the criteria of VCI. Demographic data, MRI markers of CSVD, blood pressure, vascular risk factors, laboratory markers, and serum Aβ40 and Aβ42 concentration were collected. Univariate analysis was performed with the Student’s t-test, Mann–Whitney U-test or Chi-square test. Variables with P< 0.10 in univariate analysis were then included in multivariate analysis that used a backward stepwise logistic regression model. The predictive values were assessed with receiver operating characteristic (ROC) curve.Results: VCI was determined in 112 CSVD patients (56.3%). Hyperlipidemia (OR: 1.618, 95% CI: 1.265– 3.049), the total CSVD score (OR: 1.414, 95% CI: 1.213– 2.278) and serum Aβ42 concentration (OR: 1.401, 95% CI: 1.212– 1.946) were independent risk factors for VCI in CSVD patients with adjustment for age, education years, diabetes and fasting blood-glucose (FBG). The area under curves (AUCs) were 0.640 (SE: 0.040, 95% CI: 0.563– 0.718), 0.733 (SE: 0.035, 95% CI: 0.664– 0.802) and 0.827 (SE: 0.030, 95% CI: 0.768– 0.887), respectively, for the total CSVD score, serum Aβ42 concentration and their combination applied in predicting VCI in CSVD patients. Z test demonstrated that the AUC of combination prediction was significantly higher than individual prediction (0.827 vs 0.640, Z=3.740, P< 0.001; 0.827 vs 0.733, Z=2.039, P=0.021).Conclusion: Combination of Aβ42 and total CSVD score could significantly elevate the predictive value of cognitive impairment in CSVD patients.Keywords: Aβ40, Aβ42, vascular cognitive impairment, cerebral small vessel disease, total cerebral small vessel disease score
format article
author Liu J
Zhao W
Gui Q
Zhang Y
Guo Z
Liu W
author_facet Liu J
Zhao W
Gui Q
Zhang Y
Guo Z
Liu W
author_sort Liu J
title Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
title_short Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
title_full Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
title_fullStr Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
title_full_unstemmed Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
title_sort addition of aβ42 to total cerebral small vessel disease score improves the prediction for cognitive impairment in cerebral small vessel disease patients
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/569af6e1e66f48bba1c0427cc4f4b6be
work_keys_str_mv AT liuj additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
AT zhaow additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
AT guiq additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
AT zhangy additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
AT guoz additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
AT liuw additionofabeta42tototalcerebralsmallvesseldiseasescoreimprovesthepredictionforcognitiveimpairmentincerebralsmallvesseldiseasepatients
_version_ 1718391606539714560